How to set up an effective national primary angioplasty network: lessons learned from five European countries
Language English Country France Media print
Document type Journal Article
PubMed
19736153
PII: V5I3A48
Knihovny.cz E-resources
- MeSH
- Acute Coronary Syndrome complications diagnostic imaging therapy MeSH
- Angioplasty, Balloon, Coronary * MeSH
- Benchmarking MeSH
- Time Factors MeSH
- Chronic Disease MeSH
- Organizational Objectives MeSH
- Health Services Accessibility organization & administration MeSH
- Myocardial Infarction diagnostic imaging etiology therapy MeSH
- Coronary Angiography MeSH
- Humans MeSH
- Coronary Artery Disease complications diagnostic imaging therapy MeSH
- Hospitals MeSH
- After-Hours Care organization & administration MeSH
- Patient Transfer organization & administration MeSH
- National Health Programs organization & administration MeSH
- Regional Health Planning organization & administration MeSH
- Program Development MeSH
- Practice Guidelines as Topic MeSH
- Thrombolytic Therapy MeSH
- Emergency Medical Services organization & administration MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
AIMS: Percutaneous coronary interventions (PCI) are used to treat acute and chronic forms of coronary artery disease. While in chronic forms the main goal of PCI is to improve the quality of life, in acute coronary syndromes (ACS) timely PCI is a life-saving procedure - especially in the setting of ST-elevation myocardial infarction (STEMI). The aim of this study was to describe the experience of countries with successful nationwide implementation of PCI in STEMI, and to provide general recommendations for other countries. METHODS AND RESULTS: The European Association of Percutaneous Cardiovascular Interventions (EAPCI) recenty launched the Stent For Life Initiative (SFLI). The initial phase of this pan-European project was focused on the positive experience of five countries to provide the best practice examples. The Netherlands, the Czech Republic, Sweden, Denmark and Austria were visited and the logistics of ACS treatment was studied. Public campaigns improved patient access to acute PCI. Regional networks involving emergency medical services (EMS), non-PCI hospitals and PCI centres are useful in providing access to acute PCI for most patients. Direct transfer from the first medical contact site to the cathlab is essential to minimise the time delays. Cathlab staff work is organised to provide acute PCI services 24 hours a day / seven days a week (24/7). Even in those regions where thrombolysis is still used due to long transfer distances to PCI, patients should still be transferred to a PCI centre (after thrombolysis). The highest risk non-ST elevation acute myocardial infarction patients should undergo emergency coronary angiography within two hours of hospital admission, i.e. similar to STEMI patients. CONCLUSIONS: Three realistic goals for other countries were defined based on these experiences: 1) primary PCI should be used for >70% of all STEMI patients, 2) primary PCI rates should reach >600 per million inhabitants per year and 3) existing PCI centres should treat all their STEMI patients by primary PCI, i.e. should offer a 24/7 service.
Acute revascularization in ST-segment-elevation myocardial infarction